Fatigue and primary biliary cirrhosis: Association of globus pallidus magnetisation transfer ratio measurements with fatigue severity and blood manganese levels

Gut

Volumn 53, Issue 4, 2004, Pages 587-592

  Forton, D M ^a,b   Patel, N ^b   Prince, M ^c   Oatridge, A ^b   Hamilton, G ^b   Goldblatt, J ^c   Allsop, J M ^b   Hajnal, J V ^b   Thomas, H C ^b   Bassendine, M ^c   Jones, D E J ^c   Taylor Robinson, S D ^b  

^a ST MARY S HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MANGANESE; MITOCHONDRION ANTIBODY;

ADULT; AGED; ANTIBODY TITER; ARTICLE; BLOOD LEVEL; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE SEVERITY; FATIGUE; FEMALE; GLOBUS PALLIDUS; HISTOLOGY; HUMAN; IMMUNOFLUORESCENCE; LIVER; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

ADULT; AGED; BRAIN; CHRONIC DISEASE; FATIGUE; FEMALE; GLOBUS PALLIDUS; HUMANS; LIVER CIRRHOSIS, BILIARY; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MANGANESE; MIDDLE AGED;

EID: 12144287041     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2003.016766     Document Type: Article

References (55)

1. Neuberger J. Primary biliary cirrhosis. Lancet 1997;350:875-9.
2. Prince MI, Jones DE. Primary biliary cirrhosis: new perspectives in diagnosis and treatment. Postgrad Med J 2000;76:199-206.
3. Witt-Sullivan H, Heathcote J, Cauch K, et al. The demography of primary biliary cirrhosis in Ontario, Canada. Hepatology 1990;12:98-105.
4. Cauch-Dudek K, Abbey S, Stewart DE, et al. Fatigue in primary biliary cirrhosis. Gut 1998;43:705-10.
5. Huet PM, Deslauriers J, Tran A, et al. Impact of fatigue on the quality of life of patients with primary biliary cirrhosis. Am J Gastroenterol 2000;95:760-7.
6. Goldblatt J, Taylor PJ, Lipman T, et al. The true impact of fatigue in primary biliary cirrhosis: a population study. Gastroenterology 2002;122:1235-41.
7. Prince MI, James OF, Holland NP, et al. Validation of a fatigue impact score in primary biliary cirrhosis: towards a standard for clinical and trial use. J Hepatol 2000;32:368-73.
8. Goldblatt J, James OF, Jones DE. Grip strength and subjective fatigue in patients with primary biliary cirrhosis. JAMA 2001;285:2196-7.
9. Jalan R, Gibson H, Lombard MG. Patients with PBC have central but no peripheral fatigue. Hepatology 1996;24:A612.
10. Burak KW, Le T, Swain MG. Increased sensitivity to the locomotor-activating effects of corticotropin-releasing hormone in cholestatic rats. Gastroenterology 2002;122:681-8.
11. Swain MG, Maric M. Improvement in cholestasis-associated fatigue with a serotonin receptor agonist using a novel rat model of fatigue assessment. Hepatology 1997;25:291-4.
12. Swain MG, Beck P, Rioux K, et al. Augmented interleukin-1beta-induced depression of locomotor activity in cholestatic rats. Hepatology 1998;28:1561-5.
13. Krieger D, Krieger S, Jansen O, et al. Manganese and chronic hepatic encephalopathy. Lancet 1995;346:270-4.
14. Rose C, Butterworth RF, Zayed J, et al. Manganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunction. Gastroenterology 1999;117:640-4.
15. Hauser RA, Zesiewicz TA, Martinez C, et al. Blood manganese correlates with brain magnetic resonance imaging changes in patients with liver disease. Can J Neurol Sci 1996;23:95-8.
16. Spahr L, Butterworth RF, Fontaine S, et al. Increased blood manganese in cirrhotic patients: relationship to pallidal magnetic resonance signal hyperintensity and neurological symptoms. Hepatology 1996;24:1116-20.
17. Zeneroli ML, Cioni G, Crisi G, et al. Globus pallidus alterations and brain atrophy in liver cirrhosis patients with encephalopathy: an MR imaging study. Magn Reson Imaging 1991;9:295-302.
18. Pujol J, Kulisevsky J, Moreno A, et al. Neurospectroscopic alterations and globus pallidus hyperintensity as related magnetic resonance markers of reversible hepatic encephalopathy. Neurology 1996;47:1526-30.
19. Taylor-Robinson SD, Oatridge A, Hajnal JV, et al. MR imaging of the basal ganglia in chronic liver disease: correlation of T1-weighted and magnetisation transfer contrast measurements with liver dysfunction and neuropsychiatric status. Metab Brain Dis 1995;10:175-88.
20. Dietz MC, Ihrig A, Wrazidlo W, et al. Results of magnetic resonance imaging in long-term manganese dioxide-exposed workers. Environ Res 2001;85:37-40.
21. Ikeda S, Yamaguchi Y, Sera Y, et al. Manganese deposition in the globus pallidus in patients with biliary atresia. Transplantation 2000;69:2339-43.
22. Mirowitz SA, Westrich TJ. Basal ganglial signal intensity alterations: reversal after discontinuation of parenteral manganese administration. Radiology 1992;185:535-6.
23. Hajnal JV, Baudouin CJ, Oatridge A, et al. Design and implementation of magnetization transfer pulse sequences for clinical use. J Comput Assist Tomogr 1992;16:7-18.
24. Taylor-Robinson SD, Sargentoni J, Marcus CD, et al. Regional variations in cerebral proton spectroscopy in patients with chronic hepatic encephalopathy. Metab Brain Dis 1994;9:347-59.
25. Taylor-Robinson SD, Buckley C, Changani KK, et al. Cerebral proton and phosphorus-31 magnetic resonance spectroscopy in patients with subclinical hepatic encephalopathy. Liver 1999;19:389-98.
26. 1-weighted contrast measurements with abnormalities in proton and phosphorus-31 MR spectra. Metab Brain Dis 1996;11:249-68.
27. Ross BD, Jacobson S, Villamil F, et al. Subclinical hepatic encephalopathy: proton MR spectroscopic abnormalities. Radiology 1994;193:457-63.
28. Forton DM, Allsop JM, Main J, et al. Evidence for a cerebral effect of the hepatitis C virus. Lancet 2001;358:38-9.
29. Forton DM, Thomas HC, Murphy CA, et al. Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology 2002;35:433-9.
30. Miller BL. A review of chemical issues in 1H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline. NMR Biomed 1991;4:47-52.
31. Wessely S. Chronic fatigue: symptom and syndrome. Ann Intern Med 2001;134:838-43.
32. Iwaso M, Kinosada Y, Nakatsuka A, et al. Magnetization transfer contrast of various regions of the brain in liver cirrhosis. AJNR Am J Neuroradiol 1999;20:652-4.
33. 1H-magnetic resonance abnormalities after liver transplantation. J Hepatol 2001;35:598-604.
34. 31P magnetic resonance spectroscopy reveals osmotic and metabolic disturbances in human hepatic encephalopathy. J Neurochem 1998;71:1564-76.
35. Nolte W, Wiltfang J, Schindler CG, et al. Bright basal ganglia in T1-weighted magnetic resonance images are frequent in patients with portal vein thrombosis without liver cirrhosis and not suggestive of hepatic encephalopathy. J Hepatol 1998;29:443-9.
36. Skehan S, Norris S, Hegarty J, et al. Brain MRI changes in chronic liver disease. Eur Radiol 1997;7:905-9.
37. van Buchem MA, Tofts PS. Magnetization transfer imaging. Neuroimaging Clin N Am 2000;10:771-88.
38. 1-weighted images and elemental concentrations in brain. Neuroradiology 1997;39:546-50.
39. Mehta RC, Pike GB, Enzmann DR. Magnetization transfer MR of the normal adult brain. AJNR Am J Neuroradiol 1995;16:2085-91.
40. Rovaris M, Iannucci G, Cercignani M, et al. Age-related changes in conventional, magnetization transfer, and diffusion-tensor MR imaging findings: study with whole-brain tissue histogram analysis. Radiology 2003;227:731-8.
41. Ge Y, Grossman RI, Babb JS, et al. Age-related total gray matter and white matter changes in normal adult brain. Part II: quantitative magnetization transfer ratio histogram analysis. AJNR Am J Neuroradiol 2002;23:1334-41.
42. Lee JW. Manganese intoxication. Arch Neurol 2000;57:597-9.
43. Bowler RM, Mergler D, Sassine MP, et al. Neuropsychiatric effects of manganese on mood. Neurotoxicology 1999;20:367-78.
44. Roels H, Lauwerys R, Buchet JP, et al. Epidemiological survey among workers exposed to manganese: effects on lung, central nervous system, and some biological indices. Am J Ind Med 1987;11:307-27.
45. Wedler FC. Biological significance of manganese in mammalian systems. Prog Med Chem 1993;30:89-133.
46. Conrad ME, Umbreit JN, Moore EG, et al. Separate pathways for cellular uptake of ferric and ferrous iron. Am J Physiol Gastrointest Liver Physiol 2000;279:G767-74.
47. Malecki EA, Devenyi AG, Beard JL, et al. Existing and emerging mechanisms for transport of iron and manganese to the brain. J Neurosci Res 1999;56:113-22.
48. Versieck J, Barbier F, Speecke A, et al. Manganese, copper, and zinc concentrations in serum and packed blood cells during acute hepatitis, chronic hepatitis, and posthepatitic cirrhosis. Clin Chem 1974;20:1141-5.
49. Aschner M, Vrana KE, Zheng W. Manganese uptake and distribution in the central nervous system (CNS). Neurotoxicology 1999;20:173-80.
50. Sloot WN, Gramsbergen JB. Axonal transport of manganese and its relevance to selective neurotoxicity in the rat basal ganglia. Brain Res 1994;657:124-32.
51. Middleton FA, Strick PL. Basal ganglia output and cognition: evidence from anatomical, behavioral, and clinical studies. Brain Cogn 2000;42:183-200.
52. Chaudhuri A, Behan PO. Fatigue and basal ganglia. J Neurol Sci 2000;179:34-42.
53. Friedman J, Friedman H. Fatigue in Parkinson's disease. Neurology 1993;43:2016-18.
54. Laplane D, Baulac M, Widlocher D, et al. Pure psychic akinesia with bilateral lesions of basal ganglia. J Neurol Neurosurg Psychiatry 1984;47:377-85.
55. Chen CJ, Liao SL. Oxidative stress involves in astrocytic alterations induced by manganese. Exp Neurol 2002;175:216-25.